BioSpace News Archive

Chondroitin Sulfate Market: Dietary Supplements Segment to Exhibit Dominance in Overall Market

The global chondroitin sulfate market is anticipated to witness a sluggish growth in the coming years, as reported by Transparency Market Research.

June 10, 2020
·
4 min read
Erythropoietin Drugs Market: Cancer to Remain Critical to Escalating Demand for Erythropoietin Drugs over Forecast Period

The global erythropoietin drugs market is prognosticated to demonstrate steady growth in coming years, as reported by Transparency Market Research.

June 10, 2020
·
5 min read
Plasma Protease C1-inhibitor Treatment Market: Extensive Use for HAE Makes C1-inhibitor Drug Class Dominant

The vendor landscape of the global market for plasma protease c1-inhibitor treatment market is largely consolidated with a handful of companies collectively accounting for a lion’s share in the market and maintaining a tough level of competition, observes Transparency Market Research in a recent report.

June 10, 2020
·
3 min read
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Increase in Prevalence of Chronic Pancreatitis and Cystic Fibrosis Propel Global Market

Transparency Market Research has published a new report titled, ‘Exocrine Pancreatic Insufficiency Therapeutics & Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

June 10, 2020
·
5 min read
Monopolar Electrosurgery Market: Increase in Number of Minimally Invasive Surgical Procedures Performed Each Year Boost Market Growth

Transparency Market Research has published a new report titled, ‘Monopolar Electrosurgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

June 10, 2020
·
6 min read
Business

Confo Therapeutics Expands Board with Appointment of Rob Scott as Independent Director

Confo Therapeutics announced the addition of a new member to its Board of Directors with the appointment of Rob Scott, MD, as an Independent Director.

June 10, 2020
·
3 min read
Business

AbbVie and Genmab Announce Broad Oncology Collaboration

AbbVie and Genmab entered into a broad collaboration to jointly develop and commercialize three of Genmab’s next-generation bispecific antibody products, including epcoritamab

June 10, 2020
·
11 min read
Business

Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020

Completed enrollment of cohort 2 of SUNRISE-PD Phase 2 study of AXO-Lenti-PD in Parkinson’s disease, with data from this cohort expected in Q4 2020

June 10, 2020
·
12 min read
Pharm Country

Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis

Pfizer Inc. announced positive top-line results from the Phase 3 JADE TEEN study of abrocitinib, an investigational oral once-daily Janus kinase 1 inhibitor, in patients 12 to <18 years of age with moderate to severe atopic dermatitis who were also on background topical therapy.

June 10, 2020
·
11 min read
Drug Development

Fulcrum Therapeutics to Evaluate Losmapimod as Potential Treatment for COVID-19

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced plans to evaluate losmapimod as a potential treatment for patients with COVID-19.

June 10, 2020
·
10 min read